High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation
V. Linden et al., High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation, INTEN CAR M, 26(11), 2000, pp. 1630-1637
Objectives: To evaluate the results of treatment of severe acute respirator
y distress syndrome (ARDS) with extracorporeal membrane oxygenation (ECMO),
minimal sedation, and pressure supported ventilation.
Design and setting: Observational study in a tertiary referral center, Inte
nsive Care Unit, Astrid Lindgren Children's Hospital at Karolinska Hospital
, Stockholm, Sweden.
Subjects and methods: Seventeen adult patients with ARDS were treated with
venovenous or venoarterial ECMO after failure of conventional therapy. The
Murray score of pulmonary injury averaged 3.5 (3.0-4.0) and the mean PaO2/F
IO2 ratio was 46 (31-65). A standard ECMO circuit with nonheparinized surfa
ces was used. The patients were minimally sedated and received pressure-sup
ported ventilation. High inspiratory pressures were avoided and arterial sa
turation as low as 70% was accepted on venovenous bypass.
Results: In one patient a stable bypass could not be established. Among the
remaining 16 patients 13 survived (total survival rate 76%) after 3-52 day
s (mean 15) on bypass. Major surgical procedures were performed in several
patients. The cause of death in the three nonsurvivors was intracranial com
plications leading to total cerebral infarction.
Conclusion: A high survival rate can be obtained in adult patients with sev
ere ARDS using ECMO and pressure-supported ventilation with minimal sedatio
n. Surgical complications are amenable to surgical treatment during ECMO. B
leeding problems can generally be controlled but require immediate and aggr
essive approach. It is difficult or impossible to decide when a lung diseas
e is irreversible, and prolonged ECMO treatment may be successful even in t
he absence of any detectable lung function.